Delivery Order SPE2DB20D2002-SPE2DB22FL63C
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,369.64 firm fixed-price contract is for the provision of AMOX-CLAV 875-125 100S medical supplies. The contract has an ultimate completion date of August 29, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,594.13 for the supply of AMOX-CLAV ER 1,000-62.5 MG TAB UU 28S. The contract was awarded by the Defense Logistics Agency (DLA), a Defense agency, and has a completion date of February 26, 2024. The contract type is Firm Fixed Price, and there was no set-aside designation used. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4,559,180,354 units of the pharmaceutical product AMOX-CLAV 875-125 MG TABLET 20S. The firm-fixed-price Delivery Order, valued at $1,278.51, has a period of performance ending on November 25, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of 4,558,364,911 units of Amoxicillin-Clavulanate 875-125 mg tablets in 100-count bottles to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on September 7, 2022, with a ceiling value of $3,189.64 and a completion date of September 8, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen) was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,234.98 firm fixed-price delivery order is for the supply of AMOX-CLAV 875-125 MG TABLET 20S, a pharmaceutical product. Amerisourcebergen is the prime contractor and holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Amoxicillin-Clavulanate 875-125 mg tablets (100 count) with a ceiling value of $2,146.95. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of December 18, 2025, and is being performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,546.67 firm fixed-price contract is for the supply of AMOX-CLAV 400-57 MG/5 ML SUSP 100ML, a pharmaceutical product. The contract has an ultimate completion date of May 28, 2024. AmerisourceBergen is the prime contractor and there is no indication of any major subcontractors. This contract award is not designated as...
- The federal contract award SPE2DB20D2002|SPE2DB24FL64J was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,241.30 firm fixed price delivery order is for the supply of 875-125 mg amoxicillin-clavulanic acid tablets. This contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $1,626.90 firm-fixed-price contract is for the supply of pharmaceutical and medical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies, to support military treatment facilities and federal healthcare programs. Amerisourcebergen is a major...
- This federal contract award, with ID SPE2DB20D3101|SPE2DB22FK2E0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,712.71 delivery order is for Amoxicillin-Clavulanate 400-57 mg chewable tablets, which are used to treat bacterial infections. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB22FL63CDelivery Order
This is a delivery order issued under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical by Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,919.84 firm fixed-price contract is for the delivery of 100 units of the pharmaceutical product AMOX-CLAV 875-125 MG TABLET. There is no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 IDC with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 8/17/22 |